Title
MDMA and Ketamine for Treatment Resistant PTSD and Depression
Document Type
Presentation
Loading...
Media is loading
Publication Date
10-11-2021
Abstract
Overall Goals and Objectives:
Following this activity, a participant should be able to:
- Identify recent advances in integrative medical care and discuss their application to clinical practice.
- Describe the latest data on complementary and alternative medical therapies that could improve patient outcomes.
- Discuss core integrative medicine topics that patients frequently ask physicians about.
Learning Objectives
- List 5 under-recognized contributors to treatment resistant depression
- Summarize the current status of research on MDMA for TR-PTSD
- Describe the role of set and setting in psychedelic psychotherapy
- Explain the risks of psychedelics taken in a medical setting
Recommended Citation
Van Derveer, MD, Will, "MDMA and Ketamine for Treatment Resistant PTSD and Depression" (2021). Integrative Medicine Lectures, Presentations & Grand Rounds. Presentation 128.
https://jdc.jefferson.edu/jmbcim_lectures/128
Language
English
COinS
Comments
Dr. Will Van Derveer is an integrative psychiatrist in Boulder, CO, specializing in ketamine-assisted psychotherapy for treatment-resistant depression and PTSD. He is a diplomat of the American Board of Integrative Medicine (ABOIM). Dr. Van Derveer is an advocate of recognizing the role of trauma as a lead cause of human suffering.
Presentation: 58:24